Nucleic Acids Research Response to Reviewers: How to Write a Rebuttal That Clears Re-Review (2026)
How to write a point-by-point response to reviewers for Nucleic Acids Research, where a major revision usually means the mechanistic experiment or benchmark the reviewer asked for, run on real data, with accessions deposited before you resubmit.
Readiness scan
Before you submit to Nucleic Acids Research, pressure-test the manuscript.
Run the Free Readiness Scan to catch the issues most likely to stop the paper before peer review.
Nucleic Acids Research at a glance
Key metrics to place the journal before deciding whether it fits your manuscript and career goals.
What makes this journal worth targeting
- IF 13.1 puts Nucleic Acids Research in a visible tier — citations from papers here carry real weight.
- Scope specificity matters more than impact factor for most manuscript decisions.
- Acceptance rate of ~~45% means fit determines most outcomes.
When to look elsewhere
- When your paper sits at the edge of the journal's stated scope — borderline fit rarely improves after submission.
- If timeline matters: Nucleic Acids Research takes ~45 days median. A faster-turnaround journal may suit a grant or job deadline better.
- If open access is required by your funder, verify the journal's OA agreements before submitting.
How to use this page well
These pages work best when they behave like tools, not essays. Use the quick structure first, then apply it to the exact journal and manuscript situation.
Question | What to do |
|---|---|
Use this page for | Building a point-by-point response that is easy for reviewers and editors to trust. |
Start with | State the reviewer concern clearly, then pair each response with the exact evidence or revision. |
Common mistake | Sounding defensive or abstract instead of specific about what changed. |
Best next step | Turn the response into a visible checklist or matrix before you finalize the letter. |
Quick answer: A Nucleic Acids Research response to reviewers is a point-by-point rebuttal uploaded as a single response file with the revised manuscript, and the bar that defines it is NAR's demand for mechanistic insight and functional validation, not descriptive or correlative work.
Open with a short letter to the handling editor, give a page and line number to reference every manuscript change, answer under Reviewer 1, Reviewer 2, and so on, treat a major revision as the functional experiment or benchmark run on real data, and make sure every accession number and reviewer token is live before you resubmit, because OUP returns revisions that promise data on acceptance.
Start with the Nucleic Acids Research rebuttal readiness check before you resubmit, or work through this guide by hand. For broader cluster context, see the Nucleic Acids Research journal overview.
What does a Nucleic Acids Research response to reviewers require?
The Manusights Nucleic Acids Research rebuttal scan. This guide tells you what the handling editor and the two-plus reviewers look for in a NAR rebuttal. The scan tells you whether YOUR response letter passes that check before you upload it. In our pre-submission review work with Nucleic Acids Research manuscripts and rebuttals, the patterns below are the same ones reviewers flag at re-review. Your NAR manuscript is never used to train AI and is deleted within 24 hours, under a 60-day money-back guarantee.
Three things make a Nucleic Acids Research rebuttal different from a generic one:
- NAR is mechanism-first. The journal explicitly discourages "purely descriptive data-mining studies" and requires results "interpreted in the context of biological relevance and not just show improvement in statistical parameters." A major revision almost always means new functional or mechanistic data, not better wording.
- NAR runs four very different submission tracks. A Database, Web Server, or Survey and Summary paper is judged on criteria a standard research article never touches, so your reply has to match your track.
- OUP enforces a hard data-deposition-before-submission rule. A revision that promises accessions on acceptance gets returned unread, no matter how strong the science is.
How we built this guide
We read NAR's own author guidelines, criteria-and-scope page, and data-deposition policy, plus the annual Web Server Issue editorial, checked them against community review-time reports, and compared all of it to our own pre-submission reviews of NAR rebuttals. Every claim below traces to a primary source or our review corpus.
Element | What Nucleic Acids Research expects | What reviewers flag at re-review |
|---|---|---|
Structure | Editor letter, then point-by-point under Reviewer 1, 2, in one response file | Free-form prose answering all comments together |
New data | Functional or mechanistic experiment, or a benchmark on real data | "We have clarified this in the text" with no new result |
Specificity | Page and line number for every manuscript change | "We have updated the manuscript" with no location |
Tone | Substantive on science, gracious on style | Defensive on every minor stylistic suggestion |
Data readiness | Accessions deposited and reviewer tokens live before resubmission | "Accession numbers will be provided upon acceptance" |
Consistency | Same answer to the same point across all reviewers | Different framing for Reviewer 1 vs Reviewer 2 |
Source: Nucleic Acids Research author guidelines, criteria-and-scope, and data-deposition documentation (Oxford Academic), accessed June 2026.
The copyable Nucleic Acids Research rebuttal template
Reviewers at Nucleic Acids Research read your point-by-point response alongside the revised manuscript, so a clean, scannable structure is doing real work. Copy this skeleton, then replace the bracketed text with your own changes. Keep the reviewer text and your reply in two distinct fonts or colors.
Dear Editor,
Thank you for the opportunity to revise our manuscript the manuscript title
(NAR-[ID]). We are grateful to the reviewers for their careful
reports. In response, we have added [new functional experiment /
new benchmark], revised Figure [N], deposited the [sequencing /
structural] data, and clarified the [methods / statistics] section.
A point-by-point response follows; reviewer comments are in bold and
our replies in plain text, with revised-manuscript page and line
numbers given for every change.
----------------------------------------------------------------
Reviewer 1
Comment 1.1: "The mechanism is inferred from correlation; a
functional test is needed."
Response: We agree. We have added the [knockdown / mutant / rescue]
experiment requested (new Figure 3c) showing [result], which
establishes the causal link rather than the correlation. Changed
text appears on page 8, lines 12 to 21.
Comment 1.2: "The tool is benchmarked only on simulated data."
Response: We have re-run the benchmark against [named existing
tools] on the public [dataset] and report precision and recall in
new Table 2. See page 11, lines 4 to 18, and Supplementary Table 4.
----------------------------------------------------------------
Reviewer 2
Comment 2.1: "The Data Availability statement does not give an
accession number."
Response: We have deposited the [RNA-seq] data in GEO (accession
[GSEnnnnnn], reviewer token [token]) and updated the Data
Availability statement. See page 22, lines 1 to 6.
Comment 2.2: "The biological relevance beyond a single gene is
unclear."
Response: We have extended the analysis to [N additional loci /
the genome-wide set] and added the physiological context in the
Discussion. Revised text is on page 16, lines 7 to 19.
We believe the revised manuscript now addresses each reviewer
comment and we look forward to your decision.
Sincerely,
[Corresponding author, on behalf of all authors]The template carries the four tokens that reviewers actually scan for: a letter to the editor, a Reviewer 1 / Reviewer 2 structure, explicit action language ("we have added", "we have re-run", "we have deposited"), and a page and line reference for every change.
The page-and-line rule: cite the location of every change
State the exact page and line number for each manuscript revision, and name the specific figure, table, or supplementary file you changed. At NAR, where a major revision usually lands new functional data across several figures, this is the single most-cited rebuttal failure. A reviewer who has to hunt for your change reads it as evasion. One who can click straight to page 8, lines 12 to 21, and see the new knockdown experiment finishes faster and re-reviews more favorably.
Three rules keep your locations precise:
- Never write "we have addressed this in the manuscript" without a location, because a bare acknowledgment forces the re-reviewer back into the full revised file.
- Use line numbers from the revised file, not the original, since reviewers read your reply against the version in front of them.
- Flag Supplementary placements explicitly when a new result lives in a Supplementary figure rather than the main text, because NAR moves a lot of validation data to supplements.
Reviewer-text vs author-response typography
Make the reviewer's words and your reply visually distinct. The two simplest layouts both work:
- Put the reviewer comment in bold or a colored box, with your reply in plain text directly beneath it.
- Or use two fonts: reviewer text in one face, your response in another, kept consistent through the whole letter.
At NAR this is not cosmetic. A major revision usually carries new data across several figures, so the handling editor and the two-plus reviewers are tracking many separate changes in one document. A clean two-font or two-color layout is the difference between a rebuttal a re-reviewer can follow comment by comment and one where reply and comment blur together and they skip ahead.
Tone calibration: how to phrase the hard replies
The reviewers see your tone across every comment, and the same point may be raised by more than one reviewer. A defensive reply to Reviewer 1 is visible to Reviewer 2. Calibrate.
Bad (defensive or vague) | Better (substantive and gracious) |
|---|---|
"The reviewer has misunderstood our method." | "We did not explain the method clearly; we have rewritten the Methods on page 9 to make the procedure explicit." |
"A functional experiment is outside the scope of our paper." | "We agree this strengthens the mechanism. We have added the [knockdown] rescue on page 12 (new Figure 4b) and noted the remaining open question in the Discussion." |
"We have addressed this concern." | "We have added the requested mutant control (new Figure 3b, page 11, lines 2 to 8)." |
"More bioinformatics confirms our prediction." | "We have validated the prediction experimentally (new Figure 5, page 13), so the claim no longer rests on the computational analysis alone." |
"The benchmark on simulated data is sufficient." | "We have re-run the benchmark against [named tools] on real [public dataset] data (new Table 2, page 11); the method remains the top performer on precision." |
The pattern that works: concede where the reviewer is right, do the experiment, point to the exact change, and push back only on a request that is genuinely out of scope, with a reason and an alternative analysis.
The Nucleic Acids Research reviewer culture you are writing into
Read the decision word before you write a reply
Nucleic Acids Research runs single-anonymized peer review: the reviewers know who you are, but you do not know who they are, and manuscripts are typically sent to a minimum of two reviewers. The handling editor integrates the reports and issues one of four outcomes, and the language of that outcome tells you exactly what the rebuttal has to do:
- A reject means the science is not there; a rebuttal will not move it.
- A reject with possible resubmission means the editor will read a new submission but is restarting the clock, so your response file is effectively a fresh cover letter.
- A major revisions decision means the reviewers want new data, usually a functional experiment or benchmark.
- An accept with minor revisions means the science is done and you are tidying.
A rebuttal written for a major revision when the editor offered a resubmission, or the reverse, lands wrong. Community review-time data puts the first decision for reviewed manuscripts at roughly 45 days, with a clean desk rejection often landing in one to three weeks. That is fast for a top molecular-biology journal, and it sets the planning clock for the revision you are about to write.
The mechanism-and-function bar
The defining feature of NAR is its mechanism-depth and functional-validation bar. The journal's own criteria-and-scope page:
- discourages "purely descriptive data-mining studies"
- asks that conclusions be "experimentally testable"
- states results must be "interpreted in the context of biological relevance and not just show improvement in statistical parameters"
- for computational papers, calls for "comparative benchmarking using actual experimental evidence rather than simulated data"
So when a NAR reviewer says the mechanism is inferred, they are not asking you to soften the language. They are asking for an experiment. This is the single most load-bearing fact about a NAR rebuttal.
Match your reply to your submission track
NAR publishes on four distinct tracks, and the rebuttal expectation shifts with each:
- A research article (gene regulation, DNA repair, RNA biology, structural biology) is judged on mechanism.
- A Methods paper is judged on whether the method works and is benchmarked.
- A Database or Web Server paper, which appears in NAR's annual Database Issue and Web Server Issue, is judged on whether the resource is novel, free and open without a login, benchmarked against existing tools, usable by non-bioinformaticians, and backed by a long-term maintenance plan with documentation that states the system's limitations.
- A Survey and Summary is judged on critical synthesis and expertise.
The same "we have clarified this" sentence that fails a research-article mechanism comment also fails a Web Server sustainability comment, for a different reason.
Calibrate against the field. A rebuttal at Cell or Science faces a flagship novelty bar, PLOS ONE asks for technical soundness rather than impact, and Genome Biology publishes the open-peer-review file verbatim. NAR sits in its own spot: a mechanism-and-function bar as demanding as a flagship's, a relatively fast OUP turnaround, single-anonymized review, and a hard data-deposition gate. A NAR rebuttal lives or dies on whether you did the experiment, not on how you worded the reply.
Key Insight
At Nucleic Acids Research, "the mechanism is inferred" is not a writing comment, it is an experiment request. The strongest predictor of a second round is a rebuttal that answers a functional-validation comment with more bioinformatics instead of a new wet-lab or benchmark result.
What our Nucleic Acids Research rebuttal reviews surface
In our pre-submission review work with Nucleic Acids Research submissions, the rebuttals that stall in a second revision round share a small set of recurring weaknesses. These are the same ones NAR reviewers flag at re-review. In our analysis of Nucleic Acids Research rebuttals, each weakness below maps to a specific, named failure pattern in the editorial culture, and each is testable against your own draft response before you upload it.
Answering a functional-validation request with more bioinformatics. The most common and most expensive pattern in our Nucleic Acids Research pre-submission reviews is a rebuttal that answers a request for a functional experiment with an additional computational analysis. NAR demands mechanistic insight, so when a reviewer questions whether a result is causal, adding another enrichment plot does not move the decision; adding the knockdown, mutant, or rescue control does.
Across our Nucleic Acids Research rebuttal reviews, this mismatch between the mechanism the reviewer requested and the in-silico answer the author delivered is the single strongest predictor of a third round.
A Database or Web Server paper that promises the benchmark instead of running it. For NAR's tool tracks, the second-most-common pattern we see is a rebuttal that responds to a reviewer's "compare against existing tools" or "what is the sustainability plan" comment with a sentence in the Discussion rather than a new benchmark table and a concrete maintenance commitment.
The Web Server Issue criteria are explicit that a resource must be free and open without a login, usable by non-bioinformaticians, and maintained long after publication. In our Nucleic Acids Research pre-submission reviews of tool papers, "we plan to add a comparison" reads to a reviewer as "the comparison did not survive contact with real data."
Resubmitting with accessions still marked as pending. Because OUP requires all underlying data and code to be deposited before submission, a revision whose Data Availability statement still says "accession numbers will be provided upon acceptance" is returned before re-review.
In our pre-submission review work with Nucleic Acids Research manuscripts, we routinely find a response letter that addresses every science comment well but leaves a sequencing dataset undeposited or a reviewer token expired, which costs a full round for a problem that has nothing to do with the science. Deposit to GEO, SRA, the wwPDB, or a DOI-issuing code archive, and confirm the reviewer link works, before you resubmit.
Generic acknowledgment without a page or line number. A rebuttal that says "we have revised the manuscript accordingly" forces the reviewer to hunt for the change in a long revised file. In our Nucleic Acids Research pre-submission reviews, responses that omit the location of each figure, table, or text change consistently draw a re-review comment asking where the change is, which adds a round. Every reply needs the page and line number of the revised file.
Run the experiment, run the benchmark, deposit the data, and cite the location. That four-part discipline is what separates a Nucleic Acids Research rebuttal that clears one revision round from one that stalls into a second or third. Check your Nucleic Acids Research point-by-point response for these patterns before you submit.
Readiness check
Run the scan while Nucleic Acids Research's requirements are in front of you.
See how this manuscript scores against Nucleic Acids Research's requirements before you submit.
When to comply and when to push back
Situation | Recommended approach at Nucleic Acids Research |
|---|---|
Reviewer says the mechanism is inferred from correlation | Comply. Run the functional experiment, add the figure, cite the page and line. |
Reviewer asks a tool paper to benchmark against named existing tools | Comply. Re-run on real data, report precision and recall, drop simulated-only claims. |
Reviewer requests an experiment that is genuinely out of scope | Push back with a reason, add an alternative analysis, note the open question in the Discussion. |
Reviewer flags a missing accession or undeposited dataset | Comply immediately. Deposit, add the accession and reviewer token, this is non-negotiable at NAR. |
Reviewer questions biological relevance beyond a single gene | Comply. Extend the analysis and add the physiological context NAR expects. |
Reviewer asks a Web Server paper for a sustainability plan | Comply. State the maintenance commitment and confirm free, login-free access. |
Source: Manusights pre-submission reviews of Nucleic Acids Research-targeted resubmissions, 2025 cohort.
How much work a Nucleic Acids Research rebuttal actually takes
Authors consistently underestimate the new-experiment effort and overestimate the writing effort. This breakdown is about workload, not the journal's decision clock; for the end-to-end decision schedule, see the Nucleic Acids Research review time guide.
Rebuttal task | Where the effort goes | What it costs you |
|---|---|---|
Reading and clustering reviewer reports | Finding the one mechanistic concern behind the comments | A day of careful reading, not a skim |
Running the functional experiment or benchmark | The actual bar for a major revision at NAR | The bulk of the work, often several weeks |
Depositing data and confirming reviewer tokens | GEO, SRA, wwPDB, or a DOI-issuing code archive | A day, and the most-skipped step before resubmission |
Writing the point-by-point replies | One reply plus a page and line reference per comment | Less than authors fear once the data exist |
Reconciling overlapping comments | Same answer for every reviewer who raised a point | Skipped most often, and it shows |
Source: Manusights pre-submission reviews of Nucleic Acids Research resubmissions, 2025 cohort, last updated June 7, 2026.
Honest friction: rejection on revision is real
A major-revision invitation at Nucleic Acids Research is not a soft acceptance. The revised manuscript and your point-by-point response go back to the original reviewers or to new reviewers, and the paper can still end in rejection after re-review if the new data do not establish the mechanism or the benchmark does not hold up. Two causes drive most rejections at this stage:
- The author answered a request for a functional experiment with more computation.
- A tool paper still benchmarks only on simulated data, or its code reviewers cannot install and run.
The editor can also downgrade a major revision to reject with possible resubmission, which restarts the review as a new submission rather than continuing the thread, so a weak first revision can cost you months.
Think twice before you resubmit if any of these are true:
- The response uses generic "we have addressed this" language with no page or line numbers.
- A reviewer asked for a mechanistic experiment and you answered with bioinformatics.
- A Database or Web Server reviewer asked for a benchmark or a sustainability plan and you promised it instead of running it.
- The Data Availability statement still says accessions will come on acceptance.
Fixing these before resubmission is what keeps a second round from becoming a rejection.
Red flags a Nucleic Acids Research reviewer spots in seconds
Before you upload, scan your own rebuttal for the patterns that draw an immediate re-review comment. Each is a specific, checkable thing in your draft, not a vague quality dimension.
- A reply with no location. Any "we have revised the manuscript" with no page and line number reads as evasion the moment a reviewer cannot find the change.
- Computation where an experiment was requested. A reviewer asked for functional validation and the reply only adds another in-silico analysis.
This is the single most common cause of a third round at NAR.
- A promised benchmark. A Web Server or Database paper that answers "compare against existing tools" with "we plan to add this" instead of a results table.
- A pending accession. A Data Availability statement that says data will be deposited on acceptance, which triggers an immediate return at OUP regardless of how good the science is.
How does this guide go beyond the Nucleic Acids Research author guidelines?
NAR's official guidelines tell you to upload a response file addressing all reviewer and editor comments and to follow the formatting instructions sent with the decision. They stop there. What they do not tell you is the part that changes how you write every reply:
- "The mechanism is inferred" is an experiment request, not a wording note.
- A Database or Web Server paper is judged on benchmarking and sustainability, not mechanism.
- A pending accession gets a revision returned before re-review.
- Reject-with-possible-resubmission restarts the clock as a new submission.
The patterns above come from our pre-submission reviews of Nucleic Acids Research rebuttals, and they are testable against your own draft today, not theoretical concerns. For the upstream craft of rebuttal writing, the canonical reference is William Stafford Noble's "Ten simple rules for writing a response to reviewers" in PLOS Computational Biology.
- Manusights pre-submission reviews of Nucleic Acids Research-targeted manuscripts (2025 cohort)
Frequently asked questions
Upload a single response file alongside the revised manuscript. Open with a short letter to the handling editor summarizing the major changes, especially any new mechanistic experiment, benchmark, or data deposit. Then answer each comment in order under Reviewer 1, Reviewer 2, and so on, quote the reviewer text in full, state the exact change you made, and give the page and line number in the revised manuscript. Keep reviewer text and your reply in two visually distinct fonts or colors so the editor and referees can scan it fast.
For a major revision, usually yes. NAR demands mechanistic insight and functional validation, not descriptive or correlative work, so a major revision typically means the functional experiment or biological validation the reviewer asked for, or a computational benchmark run against existing tools on real experimental data rather than promised in the letter. Answering a mechanism request with more bioinformatics is the most common reason a NAR paper goes to a second round.
Authors are typically given 30 to 60 days to complete revisions depending on the extent of the changes. With scientific justification you can request an extension up to six months total from the decision date, after which the article is automatically withdrawn. The first decision for manuscripts sent out to review usually lands around 45 days, so the overall turnaround at OUP is relatively fast for a top molecular-biology journal.
Yes. A major-revision invitation is not an acceptance. The revised manuscript and your point-by-point response go back to the original reviewers or new reviewers, who can recommend rejection if the new data do not establish the mechanism or the benchmark does not hold up. The editor can also issue a reject-with-possible-resubmission outcome, which restarts the clock as a new submission rather than continuing the same review thread.
Yes. NAR requires all data and code underlying the results to be deposited before submission, with accession numbers and reviewer access tokens in the Data Availability statement. A note saying accession numbers will be provided upon acceptance triggers an immediate return. Sequencing data go to GEO, SRA, or ArrayExpress, structures to the wwPDB or EMDB, and source code to a DOI-issuing archive such as Zenodo, because a GitHub link alone is not accepted as the sole archive.
Sources
- Author guidelines, Nucleic Acids Research (accessed June 2026)
- Criteria and scope, Nucleic Acids Research (accessed June 2026)
- Data deposition and standardization, Nucleic Acids Research (accessed June 2026)
- The 23rd annual Nucleic Acids Research Web Server Issue 2025 (accessed June 2026)
- Ten simple rules for writing a response to reviewers, William Stafford Noble, PLOS Computational Biology (accessed June 2026)
Final step
Submitting to Nucleic Acids Research?
Run the Free Readiness Scan to see score, top issues, and journal-fit signals before you submit.
Target journal carried over: Nucleic Acids Research
Anthropic Privacy Partner. Zero-retention manuscript processing.
Where to go next
Start here
Same journal, next question
- Nucleic Acids Research submission guide
- How to Avoid Desk Rejection at Nucleic Acids Research (2026)
- Nucleic Acids Research Review Time 2026: How Long to First Decision?
- Is Your Paper Ready for Nucleic Acids Research? A Guide to NAR's Three Editorial Tracks
- Nucleic Acids Research 'Under Review': What the Status Means
- Bioinformatics vs Nucleic Acids Research
Supporting reads
Conversion step
Submitting to Nucleic Acids Research?
Anthropic Privacy Partner. Zero-retention manuscript processing.